Skip to main content
. 2017 Jul 19;7:5806. doi: 10.1038/s41598-017-05296-y

Figure 8.

Figure 8

Anti-metastatic study of BBM-NPs in C57BL/6 mice melanoma model. (a)To achieve a moderately cytotoxic dose of BBM-NPs to the tumor, initially we have developed a subcutaneous tumor model (detailed protocol in materials and methods) and injected BBM-NPs at a dose of 30 mg/kg body weight on 1st, 3rd and 5th day intraperitoneally and finally sacrificed on 12th day. (i) Tumor volume in mm3. (ii) The representative picture of the tumor. (iii) Tumor weight measured in grams. Data represented above are as mean ± SEM, n = 3. (b) To evaluate the efficacy of BBM to hematogenous lung metastasis, we have injected B16F10 cells (2 × 105) to the tail vein of C57BL/6 mice (n = 3). Next, we have injected Native BBM and BBM-NPs (30 mg/kg body weight) on 0 and 2nd day of cells injection. After 45 days, the mice were sacrificed and lungs were collected and weighed. (i) The representative picture of the lungs. (ii) The weight of lungs in grams. The datas are represented as mean ± SEM, *p < 0.05, **p < 0.005 for BBM-NPs treated mice vs. Native BBM and vs. control. Arrow indicates the tumor nodule.